Drugs / Lactobacillus casei rhamnosus
Lactobacillus casei rhamnosus
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02979288 | May 2017 → Nov 2020 | bacterial infectious disease | Medical University of Vienna | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00437580 | Feb 2007 → Aug 2009 | Enterococcus faecalis infection | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00166868 | Dec 2003 → Jan 2012 | biliary atresia | National Taiwan University Hospital | Completed | No outcome recorded |
| — | NCT00621803 | Mar 2003 → Oct 2004 | Pseudomonas aeruginosa infectious disease | University Hospital, Clermont-Ferrand | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus casei rhamnosus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00437580 ↗ |
| Known as | L. Casei rhamnosus LCR 35 | “All pregnant women between 10 + 0 (10 weeks plus 0 days) and 16 + 0 (16 weeks plus 0 days) gestational weeks in study group will be treated with vaginal Lactobacilli Capsules...” NCT02979288 ↗ |
| Known as | Lcr 35 LC | “Lactobacillus casei rhamnosus (strain Lcr 35 LC)” NCT00437580 ↗ |
| Known as | Lcr 35 regenerans | “Lactobacillus casei rhamnosus (Lcr 35 regenerans)” NCT02979288 ↗ |
| Known as | Lcr regenerans | “876,9 mg Lactobacillus casei rhamnosus (Lcr regenerans) in concentration of 107 CFU/ml” NCT02979288 ↗ |
| Known as | Lcr35 | “Administration of Lactobacillus rhamnosus Lcr35 but not Escherichia coli Nissle reduced, although not significantly, the density of VRE colonization in a murine model.” PMID 20421444 ↗ Apr 20102“Probiotic Lactobacillus casei rhamnosus (Lcr35)” NCT00621803 ↗ “Lactobacillus casei rhamnosus (Lcr35)” NCT00166868 ↗ |
| Modality | Other / unclassified | “with the probiotic” NCT00437580 ↗ |
| Route | Oral | “receive twice a day either an oral dose of Lactobacillus casei rhamnosus” NCT00621803 ↗ |